This federal contract award, with an ID of SPE2DB22D1106|SPE2DB25FDRC5, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp. The contract is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML, with an ultimate completion date of December 19, 2024 and a ceiling value of $10,544.66. The contract is a Delivery Order with a Firm Fixed Price pricing type. This award does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that maintains an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
Generated 3/19/25, 9:54 AM